Clinical Trials Browser

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

NCT04710641 2025-03-06

OUTREACH2

Phase 2 Completed

8 enrolled

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

NCT06745895 2024-12-20

MATCHES

Phase NA Recruiting

350 enrolled

Gastrointestinal

Hepatitis C, Colorectal Neoplasms

NCT02143401 2024-11-22

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

29 enrolled

Gastrointestinal

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms

NCT04540081 2023-12-27

CLOVER

Phase NA Completed

20,000 enrolled

GastrointestinalOtherThoracic

Colonic Neoplasms, Hepatitis C, Herpes Zoster, Lung Neoplasms, Obesity, Pneumonia, Bacterial, Tobacco Use Cessation

NCT04653818 2023-04-04

RCT

Phase 4 Completed

84 enrolled

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Recurrence

NCT02970136 2021-12-28

Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention

Phase NA Completed

754 enrolled 9 charts

Gastrointestinal

Acquired Immunodeficiency Syndrome, Hepatitis C, Colorectal Neoplasms

NCT01821963 2020-09-24

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Phase 3 Terminated

1 enrolled 3 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Infections

NCT04546802 2020-09-14

HATCHeT

Phase 3 Withdrawn

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT04395118 2020-07-02

STOP-HCC

Phase NA Withdrawn

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT02833298 2018-10-12

Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening

Phase NA Completed

25 enrolled

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT00513461 2018-08-10

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Phase 2 Completed

110 enrolled 21 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT01804829 2017-03-15

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

Phase 3 Completed

80 enrolled

Gastrointestinal

Hepatitis, Viral, Human, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis, Virus Diseases

NCT01790633 2016-12-13

OPTISCREEN-III

Phase NA Completed

327 enrolled 9 charts

Gastrointestinal

Acquired Immunodeficiency Syndrome, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

NCT01559844 2016-07-27

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Phase 2 Completed

61 enrolled 25 charts

Gastrointestinal

Bronchiolitis Obliterans Syndrome, Hepatitis, Hepatitis C, Carcinoma, Hepatocellular

NCT01022476 2013-07-18

LIVERAL

Phase 1/2 Completed

14 enrolled

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, HIV Infections, Liver Failure, Hepatic Insufficiency

NCT01350167 2011-05-24

Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease

Phase NA Unknown

300 enrolled

Gastrointestinal

Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Liver Neoplasms, End Stage Liver Disease

NCT00822991 2010-12-30

Sonazoid Enhanced Liver Cancer Trial for Early Detection

Phase NA Unknown

760 enrolled

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT00273247 2006-01-09

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

Phase 3 Completed

150 enrolled

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

Clinical Trials

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Mondelta

MHALT

OUTREACH2

MATCHES

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

CLOVER

RCT

Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

HATCHeT

STOP-HCC

Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

OPTISCREEN-III

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

LIVERAL

Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease

Sonazoid Enhanced Liver Cancer Trial for Early Detection

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis